Unlike traditional weight loss methods that often focus solely on caloric restriction and exercise, peptide therapy takes a more nuanced approach by directly influencing the bodys physiological processes
Semaglutide (Ozempic, Wegovy) administered once weekly demonstrates injection site reaction rates of 1.2-1.4% according to FDA prescribing information
Ongoing Support: Receive ongoing support and adjustments as needed
Wegovy is licensed for adults aged 18 and over with a BMI of 30 kg/m or above, or a BMI of 27 kg/m or above alongside at least one weight-related health condition such as type 2 diabetes, high blood pressure, or high cholesterol
Why some people microdose Reducing initial side effects is the primary motivation
If hypersensitivity reactions occur, discontinue use of RYBELSUS , treat promptly per standard of care, and monitor until signs and symptoms resolve